Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients (DRESSING)
Systemic Inflammatory Response Syndrome, Bacteremia
About this trial
This is an interventional prevention trial for Systemic Inflammatory Response Syndrome focused on measuring catheter related infection, catheter dressing, prevention, Chlorhexidine impregnated dressings, Infection, catheterization
Eligibility Criteria
Inclusion Criteria:
- patients older than 18 years
- with at least a central venous catheter or an arterial catheter
- whatever the first or subsequent CVC in a same patient
- in any site of insertion (sub-clavian, jugular or femoral)
- whatever le CVC is tunnelled or not
- CVC inserted in the study ICU or immediately before by the intensisvist in the emergency unit or in the operative room,
- CVC inserted under maximal barrier precautions
Exclusion Criteria:
- pulmonary artery catheter, haemodialysis/haemodiafiltration CVCs
- known allergy to chlorhexidine
- CVC not inserted under maximal barrier precautions
- Expected duration of CVC for less than 48 hours
- CVC inserted under emergency conditions
Sites / Locations
- grenoble university hospital (medical ICU and surgical ICU)
- Saint Joseph Hospital
- University Hospital Beaujon
- University hospital Bichat Claude Bernard
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
No Intervention
Experimental
3-days dressing frequency/CHX sponge
7-days dressing frequency/CHX sponge
3-days dressing frequency/No CHX sponge
7-days dressing change/No CHX sponge
Interventions: Device: 'Chlorhexidine Sponge (Biopatch TM)' on the insertion site
Interventions: Behavioural: 7-day catheter dressing frequency Device: 'Chlorhexidine Sponge (Biopatch TM)' on the insertion site
No intervention, classical protocol of dressing frequency every 3-days and no other device
Interventions:Behavioural: 7-day catheter dressing frequency